TCL Archive In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH January 20, 1995
TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study. February 11, 2000